Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

PhotOral Licenses Technology

Facebook Twitter LinkedIn Email Comments
BOSTON, Dec. 21, 2011 — Life sciences startup PhotOral has licensed patented technology from Harvard-affiliated Forsyth Institute to develop a novel intraoral device that uses blue light for targeting and obliterating potentially harmful dental plaque microorganisms, the company announced.

The agreement enables PhotOral to commercialize Forsyth’s photomedicine portfolio, which addresses the $7 billion oral care market. Stamatis Astra, PhotOral’s founder and CEO, is fundraising an initial round to support prototype production, clinical trials and marketing operations. The company’s goal is to have its first intraoral light cleaning device available by late 2012.

Forsyth Institute, a nonprofit research organization focused on oral, craniofacial and related biomedical science based in Cambridge, will conduct PhotOral’s clinical trials.

In 2005, Forsyth founder Dr. Nikos Soukos and Dr. Max Goodson demonstrated the susceptibility of key periodontal pathogens to blue light. Their findings suggested the potential use of phototherapy as a targeted antimicrobial method to control dental plaque growth.

For more information, visit:
Dec 2011
Americasantimicrobial methodsBiophotonicsblue light technology for dental plaqueBusinessdental plaque microorganismsForsyth InstituteHarvard Universityintraoral deviceintraoral light cleaninglight sourceslight speedMassachusettsMax GoodsonNikos Soukosperiodontal pathogensPhotOralphototherapyStamatis Astra

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.